Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Stock Information for Edesa Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Edesa Biotech Inc.

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
Edesa Biotech Reports Fiscal Year 2025 Results
Edesa Biotech Announces Upcoming Conference Schedule
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Edesa Biotech Announces Chief Financial Officer Transition

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.